Fresenius Kabi Xylocaine lidocaine injection recalled for hair contamination
Hair was found in Xylocaine (lidocaine HCl Injection, USP) 1% vials distributed nationwide. The affected product is Lot #6133986 with expiration date 02/2029. No injuries have been reported.
From the FDA notice · Read the official notice ↗ · All Fresenius Kabi recalls
What to do
- Check your facility's inventory for Lot #6133986 (expiration 02/2029)
- Do not use affected vials; quarantine and return to Fresenius Kabi
- Contact Fresenius Kabi or the FDA if you have questions
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg per 50 mL (10 mg per mL), 25 Multiple-Dose Vials, 50 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-57; NDC Vial: 63323-485-03
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
This recall covers 5 products — see all of them.
Details
- Units affected
- 37,250 vials
- Illnesses reported
- None reported
- Manufactured in
- 3 Corporate Dr, N/A, Lake Zurich, IL, United States
- Classification
- Class II
- Recall number
- D-0729-2026
In the FDA's words
- Description
- Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg per 50 mL (10 mg per mL), 25 Multiple-Dose Vials, 50 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-57; NDC Vial: 63323-485-03 Presence of Particulate Matter: Hair was found in products Lot #: 6133986, Exp. Date 02/2029 Distribution: Nationwide within in the USA Affected quantity: 37,250 vials
- Hazard
- Presence of Particulate Matter: Hair was found in products
5 products in this recall
Fresenius Kabi Xylocaine, Naropin and more recalled over hair
Fresenius Kabi is recalling five injectable medicine products because hair was found in some vials. The products are Xylocaine (two sizes), Naropin, lidocaine HCl injection and glycopyrrolate injection, all made by Fresenius Kabi in Lake Zurich, Illinois, and sold nationwide. No injuries have been reported.
The agency lists each product separately. Check every one you might have.
- Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius Kabi, Lake Zurich, IL…D-0725-2026 · 59,425 vials
- Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL (20 mg per mL), 25 Single Dose Vials, 5 mL per vial, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 600…D-0726-2026 · 181,225 vials
- Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fresenius Kabi, Lake…D-0727-2026 · 92,600 vials
- Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich,…D-0728-2026 · 93,250 vials
- Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg per 50 mL (10 mg per mL), 25 Multiple-Dose Vials, 50 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich,… (this page)D-0729-2026 · 37,250 vials
More from Fresenius Kabi
See all- Tyenne (tocilizumab-aazg) injection recalled for glass particles
SeriousFDASep 2, 2026
- Fresenius Kabi morphine syringes recalled for Dilaudid label mixup
SeriousFDAAug 26, 2026